SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-134347
Filing Date
2024-05-08
Accepted
2024-05-08 17:11:26
Documents
7
Effectiveness Date
2024-05-08

Document Format Files

Seq Description Document Type Size
1 S-3ASR d825185ds3asr.htm S-3ASR 169341
2 EX-5.1 d825185dex51.htm EX-5.1 10951
3 EX-23.1 d825185dex231.htm EX-23.1 1621
4 EX-23.2 d825185dex232.htm EX-23.2 1472
5 EX-FILING FEES d825185dexfilingfees.htm EX-FILING FEES 12309
6 GRAPHIC g825185snap1.jpg GRAPHIC 3930
7 GRAPHIC g825185snap3.jpg GRAPHIC 2298
  Complete submission text file 0001193125-24-134347.txt   205599
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-279225 | Film No.: 24927452
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)